Notably, the lower band in the standard, tenascin-C purified from human glioma cell lines, was larger than the lower band from either serum sample, suggesting that different splicing of tenascin-C occurs in these two sample types or different post-translational modification patterns, for example, glycosylation or proteolytic cleavage. The gene discussed is TNC; the disease is glioma.